77 related articles for article (PubMed ID: 11180134)
1. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.
Streby KA; Shah N; Ranalli MA; Kunkler A; Cripe TP
Pediatr Blood Cancer; 2015 Jan; 62(1):5-11. PubMed ID: 25175627
[TBL] [Abstract][Full Text] [Related]
2. Reaching the target dose with one single
Fiz F; Cirone A; Righi S; Massollo M; Amoroso L; Bottoni G; Conte M; Gambaro M; Massone F; Orengo S; Bruzzone GS; Sorrentino S; Garaventa A; Piccardo A
Pediatr Blood Cancer; 2024 Mar; 71(3):e30806. PubMed ID: 38082548
[TBL] [Abstract][Full Text] [Related]
3. Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during
Taniguchi Y; Wakabayashi H; Yoneyama H; Chen Z; Morino K; Otosaki A; Yamada M; Inaki A; Kayano D; Kinuya S
Sci Rep; 2022 Jan; 12(1):47. PubMed ID: 34996922
[TBL] [Abstract][Full Text] [Related]
4. Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model.
Sever RE; Rosenblum LT; Reyes-Múgica M; Edwards WB; Malek MM; Kohanbash G
Sci Rep; 2023 Nov; 13(1):20214. PubMed ID: 37980388
[TBL] [Abstract][Full Text] [Related]
5. Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment.
Mohr H; Foscarini A; Steiger K; Ballke S; Rischpler C; Schilling F; Pellegata NS
EJNMMI Res; 2021 Dec; 11(1):121. PubMed ID: 34894301
[TBL] [Abstract][Full Text] [Related]
6. Development of Fe
Liu W; Mirzoeva S; Yuan Y; Deng J; Chen S; Lai B; Vogt S; Shah K; Shroff R; Bleher R; Jin Q; Vo N; Bazak R; Ritner C; Gutionov S; Raha S; Sedlmair J; Hirschmugl C; Jacobsen C; Paunesku T; Kalapurkal J; Woloschak GE
Cancer Nanotechnol; 2021; 12(1):12. PubMed ID: 34777621
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
[TBL] [Abstract][Full Text] [Related]
8. PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma.
Lee H; Riad A; Martorano P; Mansfield A; Samanta M; Batra V; Mach RH; Maris JM; Pryma DA; Makvandi M
J Nucl Med; 2020 Jun; 61(6):850-856. PubMed ID: 31676730
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effects and potential therapeutic response biomarkers in α-emitting
Ohshima Y; Kono N; Yokota Y; Watanabe S; Sasaki I; Ishioka NS; Sakashita T; Arakawa K
Theranostics; 2019; 9(6):1538-1549. PubMed ID: 31037122
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of radionuclide treatment using α-emitting meta-
Ohshima Y; Sudo H; Watanabe S; Nagatsu K; Tsuji AB; Sakashita T; Ito YM; Yoshinaga K; Higashi T; Ishioka NS
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):999-1010. PubMed ID: 29350258
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome of
Corroyer-Dulmont A; Falzone N; Kersemans V; Thompson J; Allen DP; Able S; Kartsonaki C; Malcolm J; Kinchesh P; Hill MA; Vojnovic B; Smart SC; Gaze MN; Vallis KA
Radiother Oncol; 2017 Sep; 124(3):488-495. PubMed ID: 28595752
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma.
DuBois SG; Matthay KK
Nucl Med Biol; 2008 Aug; 35 Suppl 1(Suppl 1):S35-48. PubMed ID: 18707633
[TBL] [Abstract][Full Text] [Related]
13. Effects of anesthetic agents on cellular 123I-MIBG transport and in vivo 123I-MIBG biodistribution.
Ko BH; Paik JY; Jung KH; Bae JS; Lee EJ; Choe YS; Kim BT; Lee KH
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):554-61. PubMed ID: 17934728
[TBL] [Abstract][Full Text] [Related]
14. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
15. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
Rutgers M; Buitenhuis CK; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Aug; 87(3):412-22. PubMed ID: 10897048
[TBL] [Abstract][Full Text] [Related]
16. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
[TBL] [Abstract][Full Text] [Related]
17. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Modak S; Zanzonico P; Carrasquillo JA; Kushner BH; Kramer K; Cheung NK; Larson SM; Pandit-Taskar N
J Nucl Med; 2016 Feb; 57(2):231-7. PubMed ID: 26742708
[TBL] [Abstract][Full Text] [Related]
18. [Radio iodized metaiodobenzylguanidine (MIBG) in the treatment of neuroblastoma: modalities and indications].
Défachelles AS; Cougnenc O; Carpentier P
Bull Cancer; 2011 May; 98(5):559-69. PubMed ID: 21609890
[TBL] [Abstract][Full Text] [Related]
19. Nuclear medicine therapy of pheochromocytoma and paraganglioma.
Troncone L; Rufini V
Q J Nucl Med; 1999 Dec; 43(4):344-55. PubMed ID: 10731785
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
